Dynamic liver dysfunction predicts poor survival in patients with EGFR-mutant non-small cell lung cancer and liver metastases treated with EGFR tyrosine kinase inhibitors.

ABSTRACT:

SUBMITTER: Zhang W 

PROVIDER: S-EPMC12917993 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature